Reviva Pharmaceuticals Holdings, Inc. (RVPH) Operating income 2019–2025
Reviva Pharmaceuticals Holdings, Inc. (RVPH) annual operating income history from SEC filings — each fiscal year as reported.
-$20.2MFY2025 · since FY2019: -$376,860 → -$20.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$20.2M | +34.4% |
| FY2024 | -$30.8M | +22.0% |
| FY2023 | -$39.5M | -39.9% |
| FY2022 | -$28.2M | -179.4% |
| FY2021 | -$10.1M | -315.0% |
| FY2020 | -$2.4M | -546.0% |
| FY2019 | -$376,860 | — |
Source: SEC XBRL filings · For reference only · Not investment advice